TIPTOP generated evidence to support C-IPTp scale-up and to inform WHO change in policy recommendation updates targeting sub-Saharan Africa.
C-IPTp has helped to increase total IPTp coverage significantly. Additionally, there is no evidence that C-IPTp negatively affects ANC attendance, and in some areas C-IPTp actually had a positive effect.
Check back soon for the HHS endline study article
Check back soon for the drug resistance study article
C-IPTp is highly cost-effective, especially in areas where IPTp uptake is low.
- Check back soon to see the cost-effective article
C-IPTp is widely accepted by women, communities and providers.
- Check back soon to see the anthropological study article.
“The answer is simple: If I am asked to take this medicine, it is to improve my health and that of my child. The advice of the CHW will not mislead me!”Pregnant woman, Vohipeno, Madagascar